Ixazomib significantly prolongs progression-free survival in high-risk relapsed/refractory myeloma patients
- Hervé Avet-Loiseau*
- , Nizar J. Bahlis
- , Wee Joo Chng
- , Tamas Masszi
- , Luisa Viterbo
- , Ludek Pour
- , Peter Ganly
- , Antonio Palumbo
- , Michele Cavo
- , Christian Langer
- , Andrzej Pluta
- , Arnon Nagler
- , Shaji Kumar
- , Dina Ben-Yehuda
- , S. Vincent Rajkumar
- , Jesus San-Miguel
- , Deborah Berg
- , Jianchang Lin
- , Helgi Van De Velde
- , Dixie Lee Esseltine
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
104
Scopus
citations